Delta Air Lines, Inc. vs Medtronic PLC — how do they compare? Delta Air Lines, Inc. trades at $82.11 (market cap $54.02B), while Medtronic PLC trades at $88.79 (market cap $112.24B). The key difference: Medtronic PLC is far larger — about 2.1× Delta Air Lines, Inc.'s market cap, and Medtronic PLC pays the higher dividend (3.28%). Which is the better fit depends on your goals — on Pluang, investors hold Delta Air Lines, Inc. for 97 Days and Medtronic PLC for 63 Days on average.
| DAL | MDT | |
|---|---|---|
Market Cap | $54.02B | $112.24B |
Volume | 9,632,845 | 105,663,236 |
Sector | Industrials | Health |
52-Week High | $93.66 | $105.35 |
52-Week Low | $55.65 | $73.75 |
Typical Hold Time | 97 Days | 63 Days |
Enterprise Value | $69.34B | $131.58B |
Dividend Yield | 1.05% | 3.28% |
Signals from Pluang's Aura AI — not financial advice
Delta Air Lines (DAL) trades at $82.17, down 0.96% on the day, with a bearish technical signal. The stock shows strong fundamentals with a P/E of 13.62 and net income margin of 5.78%, supported by three consecutive quarterly earnings beats before a recent Q3 miss. Revenue growth is steady, reaching $63.36B in 2025. Analyst sentiment remains overwhelmingly positive with an 82.22% buy rating and a consensus price target of $103.36, indicating significant upside potential.
The outlook for DAL is favorable due to robust analyst support and improving cash flows, but risks include fuel cost volatility and competitive pressures. The stock's current price near support at $81 presents a potential entry point, though macroeconomic factors and execution on growth initiatives will be critical for sustained performance.
Medtronic (MDT) trades at $88.48, up 3.47% today, with a bullish analyst consensus and a $97.80 price target. The stock shows strong fundamentals with revenue growth to $33.54B in 2025 and a net income margin of 13.93%. Recent earnings beats and a 49-year dividend growth streak highlight operational strength, though technical indicators signal a near-term bearish trend with key support at $87.
MDT presents a compelling long-term investment with stable profitability and dividend reliability, but faces risks from debt increases and competitive pressures. Upside potential exists if the company maintains earnings momentum and executes on growth initiatives, while volatility may persist due to market sentiment shifts.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Atlanta-based Delta Air Lines is one of the world's largest airlines, with a network of over 300 destinations in more than 50 countries. Delta operates a hub-and-spoke system network, where it gathers and distributes passengers across the globe through key locations such as Atlanta, New York, Salt Lake City, Detroit, Seattle, and Minneapolis-St. Paul. Delta's sale of frequent flier miles, particularly to American Express, is a major driver of the firm's profits.
Read more on DAL →One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →